SCOPOLAMINE HYDROBROMIDE: 298 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
298
Total FAERS Reports
50 (16.8%)
Deaths Reported
91
Hospitalizations
298
As Primary/Secondary Suspect
20
Life-Threatening
13
Disabilities
First Report: 20110101 · Latest Report: 20240321
What Are the Most Common SCOPOLAMINE HYDROBROMIDE Side Effects?
#1 Most Reported
Off label use
89 reports (29.9%)
#2 Most Reported
Hypersensitivity
84 reports (28.2%)
#3 Most Reported
Headache
84 reports (28.2%)
All SCOPOLAMINE HYDROBROMIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 89 | 29.9% | 2 | 16 |
| Headache | 84 | 28.2% | 0 | 10 |
| Hypersensitivity | 84 | 28.2% | 0 | 10 |
| Angioedema | 83 | 27.9% | 0 | 10 |
| Drug intolerance | 82 | 27.5% | 1 | 12 |
| Dysphonia | 81 | 27.2% | 0 | 10 |
| Swelling face | 81 | 27.2% | 0 | 10 |
| Swollen tongue | 81 | 27.2% | 0 | 10 |
| Drug ineffective for unapproved indication | 70 | 23.5% | 0 | 10 |
| Drug ineffective | 42 | 14.1% | 1 | 14 |
| Product use in unapproved indication | 33 | 11.1% | 1 | 12 |
| Myocardial infarction | 20 | 6.7% | 1 | 0 |
| Blood triglycerides increased | 19 | 6.4% | 0 | 0 |
| High density lipoprotein decreased | 19 | 6.4% | 0 | 0 |
| Lower respiratory tract infection | 19 | 6.4% | 15 | 0 |
| Red cell distribution width increased | 19 | 6.4% | 0 | 0 |
| Leukocytosis | 18 | 6.0% | 14 | 0 |
| Neutrophilia | 18 | 6.0% | 14 | 0 |
| Progressive multiple sclerosis | 18 | 6.0% | 0 | 0 |
| Death | 17 | 5.7% | 17 | 3 |
Who Reports SCOPOLAMINE HYDROBROMIDE Side Effects? Age & Gender Data
Gender: 67.7% female, 32.3% male. Average age: 48.5 years. Most reports from: GB. View detailed demographics →
Is SCOPOLAMINE HYDROBROMIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 20 | 0 | 0 |
| 2014 | 2 | 1 | 0 |
| 2015 | 1 | 0 | 1 |
| 2016 | 40 | 15 | 25 |
| 2017 | 6 | 0 | 4 |
| 2018 | 2 | 0 | 1 |
| 2019 | 5 | 0 | 1 |
| 2020 | 12 | 0 | 6 |
| 2021 | 8 | 0 | 0 |
| 2022 | 11 | 6 | 1 |
| 2023 | 8 | 0 | 2 |
| 2024 | 21 | 15 | 0 |
What Is SCOPOLAMINE HYDROBROMIDE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 131 |
| Migraine | 68 |
| Salivary hypersecretion | 42 |
| Anaesthesia | 6 |
| Motion sickness | 6 |
SCOPOLAMINE HYDROBROMIDE vs Alternatives: Which Is Safer?
SCOPOLAMINE HYDROBROMIDE vs SEBELIPASE ALFA
SCOPOLAMINE HYDROBROMIDE vs SECNIDAZOLE
SCOPOLAMINE HYDROBROMIDE vs SECUKINUMAB
SCOPOLAMINE HYDROBROMIDE vs SELADELPAR LYSINE
SCOPOLAMINE HYDROBROMIDE vs SELEGILINE
SCOPOLAMINE HYDROBROMIDE vs SELENIUM
SCOPOLAMINE HYDROBROMIDE vs SELENIUM SULFIDE
SCOPOLAMINE HYDROBROMIDE vs SELEXIPAG
SCOPOLAMINE HYDROBROMIDE vs SELINEXOR
SCOPOLAMINE HYDROBROMIDE vs SELPERCATINIB
Official FDA Label for SCOPOLAMINE HYDROBROMIDE
Official prescribing information from the FDA-approved drug label.